EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ru(II) Complexes with 3,4-Dimethylphenylhydrazine: Exploring In Vitro Anticancer Activity and Protein Affinities

Jasmina Dimitrić Marković iD, Dušan Dimić iD, Thomas Eichhorn iD, Dejan Milenković, Aleksandra Pavićević iD, Dragoslava Đikić, Emilija Živković iD, Vladan Čokić iD, Tobias Rüffer, Goran N Kaluđerović iD

Biomolecules · 2025

DOI: 10.3390/biom15030350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Jasmina Dimitrić Marković und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Physical Chemistry, University of Belgrade, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Antineoplastic Agents, Coordination Complexes, Ruthenium, Hydrazines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation, Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Two new Ru(II) complexes, mononuclear [RuCl2(η6-p-cymene)(3,4-dmph-κN)] (1) and the binuclear complex [{RuCl(η6-p-cymene)}2(μ-Cl)(μ-3,4-dmph-κ2N,N′)]Cl (2; 3,4-dmph = 3,4-dimethylphenylhydrazine), are synthesized and experimentally and theoretically structurally characterized utilizing 1H and 13C NMR and FTIR spectroscopy, as well as DFT calculations. Degradation product of 2, thus ([{RuCl(η6-p-cymene)}2(μ-Cl)(μ-3,4-dmph-κ2N,N′)][RuCl3(η6-p-cymene)] (2b) was characterized with SC-XRD. In the crystals of 2b, the cationic and anionic parts interact through N-H...Cl hydrogen bridges. The spectrofluorimetric measurements proved the spontaneity of the binding processes of both complexes and HSA. Spin probing EPR measurements implied that 1 and 2 decreased the amount of bound 16-doxylstearate and implicated their potential to bind to HSA more strongly than the spin probe. The cytotoxicity assessment of both complexes against the MDA-MB-231 and MIA PaCa-2 cancer cell lines demonstrated a clear dose-dependent decrease in cell viability and no effect on healthy HS-5 cells. Determination of the malondialdehyde and protein carbonyl concentrations indicated that new complexes could offer protective antioxidant benefits in specific cancer contexts. Gel electrophoresis measurements showed the reduction in MMP9 activity and indicated the potential of 1 in limiting the cancer cells’ invasion. The annexin V/PI apoptotic assay results showed that 1 and 2 exhibit different selectivity towards MIA PaCa-2 and MDA-MB-231 cancer cells. A comparative molecular docking analysis of protein binding, specifically targeting acetylcholinesterase (ACHE), matrix metalloproteinase-9 (MMP-9), and human serum albumin (HSA), demonstrated distinct binding interactions for each complex.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsCoordination ComplexesRutheniumHydrazinesHumansCell Line, TumorMatrix Metalloproteinase 9ApoptosisProtein BindingMolecular Docking SimulationCell Survival

Stichwörter der Autor:innen

HSAMDA/PC levelsMIA PaCa-2/MDA-MB-231/HS-5 cellsRu(II) complexescell cyclespin-probing

Substanzen

Antineoplastic AgentsCoordination ComplexesRutheniumMatrix Metalloproteinase 9Hydrazines

Autor:innen und Institutionen

  • Faculty of Physical Chemistry, University of Belgrade, 11000 Belgrade, Serbia.
  • Department of Engineering and Natural Sciences, University of Applied Sciences Merseburg, D-06217 Merseburg, Germany.
  • Department of Science, Institute for Information Technologies, University of Kragujevac, 34000 Kragujevac, Serbia.
  • Institute for Medical Research, University of Belgrade, 11000 Belgrade, Serbia.
  • Institute of Chemistry, Chemnitz University of Technology, Straße der Nationen 62, D-09111 Chemnitz, Germany.

ORCID-Profile: Jasmina Dimitrić Marković, Dušan Dimić, Thomas Eichhorn, Aleksandra Pavićević, Emilija Živković, Vladan Čokić, Goran N Kaluđerović

Förderung

  • Ministry of Science, Technological Development and Innovation, Serbia

Zitieren

APA

Dimitrić Marković, J., Dimić, D., Eichhorn, T., Milenković, D., Pavićević, A., Đikić, D., Živković, E., Čokić, V., Rüffer, T., & Kaluđerović, G. N. (2025). Ru(II) Complexes with 3,4-Dimethylphenylhydrazine: Exploring In Vitro Anticancer Activity and Protein Affinities. Biomolecules. https://doi.org/10.3390/biom15030350

Vancouver

Dimitrić Marković J, Dimić D, Eichhorn T, Milenković D, Pavićević A, Đikić D, et al. Ru(II) Complexes with 3,4-Dimethylphenylhydrazine: Exploring In Vitro Anticancer Activity and Protein Affinities. Biomolecules. 2025. doi:10.3390/biom15030350

BibTeX
@article{DimitriMarkovi2025,
  author = {Dimitrić Marković, Jasmina and Dimić, Dušan and Eichhorn, Thomas and Milenković, Dejan and Pavićević, Aleksandra and Đikić, Dragoslava and Živković, Emilija and Čokić, Vladan and Rüffer, Tobias and Kaluđerović, Goran N},
  title = {Ru(II) Complexes with 3,4-Dimethylphenylhydrazine: Exploring In Vitro Anticancer Activity and Protein Affinities},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15030350}
}
Kostenlos starten →